Informație de încredere. Sprijin real.

Ai întrebări despre autism, ADHD, anxietate sau depresie? Găsești ghiduri clare, verificate de specialiști. Acum, acces gratuit.

Spațiu publicitar disponibil — bannerul mare de susSpațiu publicitar disponibil — bannerul mare de sus

Explorează temele

Caută tot →

Sănătate mintală și neurodezvoltare

Afecțiuni neurologice

Articole și ghiduri recomandate

StudiuDemențeÎncredere bună21.06.2026

Cognitive Reserve and Alzheimer's Disease: Impact on Risk and Progression—A Literature Review

This review examines cognitive reserve (CR), the brain's ability to compensate for pathology through adaptive mechanisms, as a crucial factor in reducing Alzheimer's disease risk and slowing cognitive decline. The authors evaluate measurement methods, interventions, and practical applications, noting that lifestyle choices and occupational complexity may be more informative than education alone in capturing CR complexity.

StudiuDemențeÎncredere bună21.06.2026

Multicenter Open-Label Trial of Ginkgo Biloba Extract EGb 761® for Cognitive Decline in Major Neurocognitive Disorder

A prospective study of 150 patients aged 50+ with Alzheimer's disease or vascular dementia receiving 120 mg of Ginkgo biloba extract twice daily for 18 weeks demonstrated significant improvements in constructional praxis, memory, executive function, and behavioral symptoms using validated cognitive measures. Adverse events were reported in 22% of patients, with no serious safety concerns identified.

StudiuDemențeÎncredere bună21.06.2026

Clinical Characterization of Amyloid-Negative ATN Profiles in Dementia Diagnosis

This study examined 92 amyloid-negative patients using the ATN biomarker classification framework to identify non-Alzheimer's pathologies causing cognitive decline. Results showed amyloid-negative profiles were associated with non-Alzheimer's dementia types and secondary neuropsychiatric conditions, though early-stage misclassification risks warrant further investigation.

StudiuDemențeÎncredere înaltă20.06.2026

Cerebrospinal Fluid Proteomics Identifies Proteins Associated with Cognitive Decline in Amyloid-Beta Positive Older Adults

This proteomics study analyzed cerebrospinal fluid from 490 amyloid-positive participants to identify 61 dysregulated proteins that distinguish those with Alzheimer's dementia from cognitively normal or mildly impaired individuals. The identified proteins were associated with cognitive progression and diagnostic conversion, with functional enrichment analyses revealing pathways relevant to neurodegeneration.